Diagonal Bio
0.026
SEK
+5.31 %
DIABIO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
2 following
+5.31%
-25.22%
+100%
-16.5%
-87.94%
-89.36%
-99.25%
-
-99.52%
Diagonal Bio operates in the biotechnology industry. The company is developing a platform under the name Panviral to detect and diagnose small sections of pathogen genomes, such as viruses, bacteria, and fungi. In addition to the main business, service and associated ancillary services are also offered. The largest operations take place in Sweden with headquarter in Lund.
Read moreMarket cap
10.34M SEK
Turnover
18.89K SEK
Revenue
20K
EBIT %
-57,850 %
P/E
-
Dividend yield-%
-
Financial calendar
25/2
2025
Annual report '24
14/5
2025
Interim report Q1'25
20/5
2025
General meeting '24
ShowingAll content types
Valberedning utsedd i Diagonal Bio AB (publ) inför årsstämman 2025
Diagonal Bio AB: Nomination Committee appointed for Diagonal Bio
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools